APO Research
Talk to an analyst

APO RESEARCH · REPORT

Circulating Tumor Cells

Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of these markers in monitoring disease progression and potentially guiding personalized cancer therapy.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of these markers in monitoring disease progression and potentially guiding personalized cancer therapy.

Selected research

Industry Growth & Trends

Global Circulating Tumor Cells Industry Growth and Trends Forecast to 2032

21 December 2025111 pages

Choose your research edition.

Industry ResearchCirculating Tumor Cells Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Circulating Tumor Cells Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Circulating Tumor Cells Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Circulating Tumor Cells Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal Circulating Tumor Cells Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of these markers in monitoring disease progression and potentially guiding personalized cancer therapy.

According to APO Research, the global Circulating Tumor Cells market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Circulating Tumor Cells market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Circulating Tumor Cells market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Circulating Tumor Cells market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Circulating Tumor Cells.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Circulating Tumor Cells market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Circulating Tumor Cells Market by Company

Menarini-Silicon Biosystems

Qiagen (Adnagen)

Advanced Cell Diagnostics

ApoCell

Epic Sciences

Greiner Bio-one GmbH

Cynvenio

SurExamBio-Tech

Fluxion Biosciences

Ikonisys

Hangzhou Watson Biotech

Biocept

CytoTrack

Guangzhou Wondfo Biotech

Celsee

Clearbridge Biomedics

ANGLE plc

Circulating Tumor Cells Segment by Type

CTC Enrichment

CTC Detection

CTC Analysis

Circulating Tumor Cells Segment by Application

Breast Cancer

Prostate Cancer

Colorectal Cancer

Lung Cancer

Others

Circulating Tumor Cells Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Circulating Tumor Cells market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Circulating Tumor Cells and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Circulating Tumor Cells.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Circulating Tumor Cells companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Circulating Tumor Cells Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Circulating Tumor Cells Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Circulating Tumor Cells Market Share by Region (2021-2026) Table 4. Global Circulating Tumor Cells Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Circulating Tumor Cells Market Share by Region (2027-2032) Table 6. Global Circulating Tumor Cells Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Circulating Tumor Cells Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Circulating Tumor Cells Market Size Share by Type (2021-2026) Table 9. Global Circulating Tumor Cells Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Circulating Tumor Cells Market Size Share Forecasted by Type (2027-2032) Table 11. North America Circulating Tumor Cells Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Circulating Tumor Cells Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Circulating Tumor Cells Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Circulating Tumor Cells Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Circulating Tumor Cells Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Circulating Tumor Cells Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Circulating Tumor Cells Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Circulating Tumor Cells Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Circulating Tumor Cells Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Circulating Tumor Cells Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Circulating Tumor Cells Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Circulating Tumor Cells Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Circulating Tumor Cells Market Size Share by Application (2021-2026) Table 24. Global Circulating Tumor Cells Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Circulating Tumor Cells Market Size Share Forecasted by Application (2027-2032) Table 26. North America Circulating Tumor Cells Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Circulating Tumor Cells Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Circulating Tumor Cells Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Circulating Tumor Cells Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Circulating Tumor Cells Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Circulating Tumor Cells Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Circulating Tumor Cells Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Circulating Tumor Cells Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Circulating Tumor Cells Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Circulating Tumor Cells Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Circulating Tumor Cells Industry Trends Table 37. Circulating Tumor Cells Industry Drivers Table 38. Circulating Tumor Cells Industry Opportunities and Challenges Table 39. Circulating Tumor Cells Industry Restraints Table 40. Global Circulating Tumor Cells Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Circulating Tumor Cells Revenue Market Share by Company (2021-2026) Table 42. Global Circulating Tumor Cells Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Circulating Tumor Cells Key Company Headquarters & Area Served Table 44. Global Circulating Tumor Cells Company, Product Type & Application Table 45. Global Circulating Tumor Cells Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Circulating Tumor Cells by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Menarini-Silicon Biosystems Company Information Table 49. Menarini-Silicon Biosystems Business Overview Table 50. Menarini-Silicon Biosystems Circulating Tumor Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Menarini-Silicon Biosystems Circulating Tumor Cells Product Portfolio Table 52. Menarini-Silicon Biosystems Recent Development Table 53. Qiagen (Adnagen) Company Information Table 54. Qiagen (Adnagen) Business Overview Table 55. Qiagen (Adnagen) Circulating Tumor Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Qiagen (Adnagen) Circulating Tumor Cells Product Portfolio Table 57. Qiagen (Adnagen) Recent Development Table 58. Advanced Cell Diagnostics Company Information Table 59. Advanced Cell Diagnostics Business Overview Table 60. Advanced Cell Diagnostics Circulating Tumor Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Advanced Cell Diagnostics Circulating Tumor Cells Product Portfolio Table 62. Advanced Cell Diagnostics Recent Development Table 63. ApoCell Company Information Table 64. ApoCell Business Overview Table 65. ApoCell Circulating Tumor Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. ApoCell Circulating Tumor Cells Product Portfolio Table 67. ApoCell Recent Development Table 68. Epic Sciences Company Information Table 69. Epic Sciences Business Overview Table 70. Epic Sciences Circulating Tumor Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Epic Sciences Circulating Tumor Cells Product Portfolio Table 72. Epic Sciences Recent Development Table 73. Greiner Bio-one GmbH Company Information Table 74. Greiner Bio-one GmbH Business Overview Table 75. Greiner Bio-one GmbH Circulating Tumor Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Greiner Bio-one GmbH Circulating Tumor Cells Product Portfolio Table 77. Greiner Bio-one GmbH Recent Development Table 78. Cynvenio Company Information Table 79. Cynvenio Business Overview Table 80. Cynvenio Circulating Tumor Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Cynvenio Circulating Tumor Cells Product Portfolio Table 82. Cynvenio Recent Development Table 83. SurExamBio-Tech Company Information Table 84. SurExamBio-Tech Business Overview Table 85. SurExamBio-Tech Circulating Tumor Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. SurExamBio-Tech Circulating Tumor Cells Product Portfolio Table 87. SurExamBio-Tech Recent Development Table 88. Fluxion Biosciences Company Information Table 89. Fluxion Biosciences Business Overview Table 90. Fluxion Biosciences Circulating Tumor Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Fluxion Biosciences Circulating Tumor Cells Product Portfolio Table 92. Fluxion Biosciences Recent Development Table 93. Ikonisys Company Information Table 94. Ikonisys Business Overview Table 95. Ikonisys Circulating Tumor Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Ikonisys Circulating Tumor Cells Product Portfolio Table 97. Ikonisys Recent Development Table 98. Hangzhou Watson Biotech Company Information Table 99. Hangzhou Watson Biotech Business Overview Table 100. Hangzhou Watson Biotech Circulating Tumor Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Hangzhou Watson Biotech Circulating Tumor Cells Product Portfolio Table 102. Hangzhou Watson Biotech Recent Development Table 103. Biocept Company Information Table 104. Biocept Business Overview Table 105. Biocept Circulating Tumor Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Biocept Circulating Tumor Cells Product Portfolio Table 107. Biocept Recent Development Table 108. CytoTrack Company Information Table 109. CytoTrack Business Overview Table 110. CytoTrack Circulating Tumor Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. CytoTrack Circulating Tumor Cells Product Portfolio Table 112. CytoTrack Recent Development Table 113. Guangzhou Wondfo Biotech Company Information Table 114. Guangzhou Wondfo Biotech Business Overview Table 115. Guangzhou Wondfo Biotech Circulating Tumor Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Guangzhou Wondfo Biotech Circulating Tumor Cells Product Portfolio Table 117. Guangzhou Wondfo Biotech Recent Development Table 118. Celsee Company Information Table 119. Celsee Business Overview Table 120. Celsee Circulating Tumor Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Celsee Circulating Tumor Cells Product Portfolio Table 122. Celsee Recent Development Table 123. Clearbridge Biomedics Company Information Table 124. Clearbridge Biomedics Business Overview Table 125. Clearbridge Biomedics Circulating Tumor Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Clearbridge Biomedics Circulating Tumor Cells Product Portfolio Table 127. Clearbridge Biomedics Recent Development Table 128. ANGLE plc Company Information Table 129. ANGLE plc Business Overview Table 130. ANGLE plc Circulating Tumor Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. ANGLE plc Circulating Tumor Cells Product Portfolio Table 132. ANGLE plc Recent Development Table 133. North America Circulating Tumor Cells Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. North America Circulating Tumor Cells Market Size by Country (2021-2026) & (US$ Million) Table 135. North America Circulating Tumor Cells Market Share by Country (2021-2026) Table 136. North America Circulating Tumor Cells Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. North America Circulating Tumor Cells Market Share Forecast by Country (2027-2032) Table 138. Europe Circulating Tumor Cells Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Europe Circulating Tumor Cells Market Size by Country (2021-2026) & (US$ Million) Table 140. Europe Circulating Tumor Cells Market Share by Country (2021-2026) Table 141. Europe Circulating Tumor Cells Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Europe Circulating Tumor Cells Market Share Forecast by Country (2027-2032) Table 143. Asia-Pacific Circulating Tumor Cells Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Asia-Pacific Circulating Tumor Cells Market Size by Country (2021-2026) & (US$ Million) Table 145. Asia-Pacific Circulating Tumor Cells Market Share by Country (2021-2026) Table 146. Asia-Pacific Circulating Tumor Cells Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Asia-Pacific Circulating Tumor Cells Market Share Forecast by Country (2027-2032) Table 148. Latin America Circulating Tumor Cells Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Latin America Circulating Tumor Cells Market Size by Country (2021-2026) & (US$ Million) Table 150. Latin America Circulating Tumor Cells Market Share by Country (2021-2026) Table 151. Latin America Circulating Tumor Cells Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Latin America Circulating Tumor Cells Market Share Forecast by Country (2027-2032) Table 153. Middle East & Africa Circulating Tumor Cells Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Middle East & Africa Circulating Tumor Cells Market Size by Country (2021-2026) & (US$ Million) Table 155. Middle East & Africa Circulating Tumor Cells Market Share by Country (2021-2026) Table 156. Middle East & Africa Circulating Tumor Cells Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Middle East & Africa Circulating Tumor Cells Market Share Forecast by Country (2027-2032) Table 158. Research Programs/Design for This Report Table 159. Authors List of This Report Table 160. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Circulating Tumor Cells Product Image Figure 3. Global Circulating Tumor Cells Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Circulating Tumor Cells Market Size (2021-2032) & (US$ Million) Figure 5. Global Circulating Tumor Cells Market Share by Region: 2025 VS 2032 Figure 6. Global Circulating Tumor Cells Market Share by Region (2021-2032) Figure 7. North America Circulating Tumor Cells Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Circulating Tumor Cells Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Circulating Tumor Cells Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Circulating Tumor Cells Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Circulating Tumor Cells Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. CTC Enrichment Image Figure 13. Global CTC Enrichment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. CTC Detection Image Figure 15. Global CTC Detection Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. CTC Analysis Image Figure 17. Global CTC Analysis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Global Circulating Tumor Cells Market Size Overview by Type (2021-2032) & (US$ Million) Figure 19. Global Circulating Tumor Cells Market Share by Type 2025 VS 2032 Figure 20. North America Circulating Tumor Cells Market Size Share by Type (2021-2032) Figure 21. Europe Circulating Tumor Cells Market Size Share by Type (2021-2032) Figure 22. Asia-Pacific Circulating Tumor Cells Market Size Share by Type (2021-2032) Figure 23. Latin America Circulating Tumor Cells Market Size Share by Type (2021-2032) Figure 24. Middle East and Africa Circulating Tumor Cells Market Size Share by Type (2021-2032) Figure 25. Breast Cancer Image Figure 26. Global Breast Cancer Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Prostate Cancer Image Figure 28. Global Prostate Cancer Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Colorectal Cancer Image Figure 30. Global Colorectal Cancer Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Lung Cancer Image Figure 32. Global Lung Cancer Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Others Image Figure 34. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Global Circulating Tumor Cells Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Circulating Tumor Cells Market Share by Application 2025 VS 2032 Figure 37. North America Circulating Tumor Cells Market Size Share by Application (2021-2032) Figure 38. Europe Circulating Tumor Cells Market Size Share by Application (2021-2032) Figure 39. Asia-Pacific Circulating Tumor Cells Market Size Share by Application (2021-2032) Figure 40. Latin America Circulating Tumor Cells Market Size Share by Application (2021-2032) Figure 41. Middle East and Africa Circulating Tumor Cells Market Size Share by Application (2021-2032) Figure 42. Global Top 5 and 10 Circulating Tumor Cells Players Market Share by Revenue in 2025 Figure 43. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 44. North America Circulating Tumor Cells Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. North America Circulating Tumor Cells Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. North America Circulating Tumor Cells Market Share by Country (2021-2032) Figure 47. Europe Circulating Tumor Cells Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Circulating Tumor Cells Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Circulating Tumor Cells Market Share by Country (2021-2032) Figure 50. Asia-Pacific Circulating Tumor Cells Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Asia-Pacific Circulating Tumor Cells Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Asia-Pacific Circulating Tumor Cells Market Share by Country (2021-2032) Figure 53. Latin America Circulating Tumor Cells Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Circulating Tumor Cells Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Circulating Tumor Cells Market Share by Country (2021-2032) Figure 56. Middle East & Africa Circulating Tumor Cells Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Middle East & Africa Circulating Tumor Cells Market Share by Country: 2021 VS 2025 VS 2032 Figure 58. Middle East & Africa Circulating Tumor Cells Market Share by Country (2021-2032) Figure 59. Years Considered Figure 60. Research Process Figure 61. Key Executives Interviewed

Scope & coverage.

Types
  • CTC Enrichment
  • CTC Detection
  • CTC Analysis
Applications
  • Breast Cancer
  • Prostate Cancer
  • Colorectal Cancer
  • Lung Cancer
  • Others
Companies covered
  • Menarini-Silicon Biosystems
  • Qiagen (Adnagen)
  • Advanced Cell Diagnostics
  • ApoCell
  • Epic Sciences
  • Greiner Bio-one GmbH
  • Cynvenio
  • SurExamBio-Tech
  • Fluxion Biosciences
  • Ikonisys
  • Hangzhou Watson Biotech
  • Biocept
  • CytoTrack
  • Guangzhou Wondfo Biotech
  • Celsee
  • Clearbridge Biomedics
  • ANGLE plc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Circulating Tumor Cells Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Circulating Tumor Cells Market Size by Region (2021-2032)
  5. 1.4.1 Global Circulating Tumor Cells Market Size by Region (2021-2026)
  6. 1.4.2 Global Circulating Tumor Cells Market Size by Region (2027-2032)
  7. 1.5 Key Regions Circulating Tumor Cells Market Size (2021-2032)
  8. 1.5.1 North America Circulating Tumor Cells Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Circulating Tumor Cells Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Circulating Tumor Cells Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Circulating Tumor Cells Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Circulating Tumor Cells Market Size Growth Rate (2021-2032)
2 Circulating Tumor Cells Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 CTC Enrichment
  3. 2.1.2 CTC Detection
  4. 2.1.3 CTC Analysis
  5. 2.2 Global Circulating Tumor Cells Market Size by Type
  6. 2.2.1 Global Circulating Tumor Cells Market Size Overview by Type (2021-2032)
  7. 2.2.2 Global Circulating Tumor Cells Historic Market Size Review by Type (2021-2026)
  8. 2.2.3 Global Circulating Tumor Cells Market Size Forecasted by Type (2027-2032)
  9. 2.3 Global Circulating Tumor Cells Market Size by Regions
  10. 2.3.1 North America Circulating Tumor Cells Market Size Breakdown by Type (2021-2026)
  11. 2.3.2 Europe Circulating Tumor Cells Market Size Breakdown by Type (2021-2026)
  12. 2.3.3 Asia-Pacific Circulating Tumor Cells Market Size Breakdown by Type (2021-2026)
  13. 2.3.4 South America Circulating Tumor Cells Market Size Breakdown by Type (2021-2026)
  14. 2.3.5 Middle East and Africa Circulating Tumor Cells Market Size Breakdown by Type (2021-2026)
3 Circulating Tumor Cells Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Breast Cancer
  3. 3.1.2 Prostate Cancer
  4. 3.1.3 Colorectal Cancer
  5. 3.1.4 Lung Cancer
  6. 3.1.5 Others
  7. 3.2 Global Circulating Tumor Cells Market Size by Application
  8. 3.2.1 Global Circulating Tumor Cells Market Size Overview by Application (2021-2032)
  9. 3.2.2 Global Circulating Tumor Cells Historic Market Size Review by Application (2021-2026)
  10. 3.2.3 Global Circulating Tumor Cells Market Size Forecasted by Application (2027-2032)
  11. 3.3 Global Circulating Tumor Cells Market Size by Regions
  12. 3.3.1 North America Circulating Tumor Cells Market Size Breakdown by Application (2021-2026)
  13. 3.3.2 Europe Circulating Tumor Cells Market Size Breakdown by Application (2021-2026)
  14. 3.3.3 Asia-Pacific Circulating Tumor Cells Market Size Breakdown by Application (2021-2026)
  15. 3.3.4 South America Circulating Tumor Cells Market Size Breakdown by Application (2021-2026)
  16. 3.3.5 Middle East and Africa Circulating Tumor Cells Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Circulating Tumor Cells Industry Trends
  2. 4.2 Circulating Tumor Cells Industry Drivers
  3. 4.3 Circulating Tumor Cells Industry Opportunities and Challenges
  4. 4.4 Circulating Tumor Cells Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Circulating Tumor Cells Revenue (2021-2026)
  2. 5.2 Global Circulating Tumor Cells Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Circulating Tumor Cells Key Company Headquarters & Area Served
  4. 5.4 Global Circulating Tumor Cells Company, Product Type & Application
  5. 5.5 Global Circulating Tumor Cells Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Circulating Tumor Cells Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Circulating Tumor Cells Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Circulating Tumor Cells Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Menarini-Silicon Biosystems
  2. 6.1.1 Menarini-Silicon Biosystems Company Information
  3. 6.1.2 Menarini-Silicon Biosystems Business Overview
  4. 6.1.3 Menarini-Silicon Biosystems Circulating Tumor Cells Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Menarini-Silicon Biosystems Circulating Tumor Cells Product Portfolio
  6. 6.1.5 Menarini-Silicon Biosystems Recent Developments
  7. 6.2 Qiagen (Adnagen)
  8. 6.2.1 Qiagen (Adnagen) Company Information
  9. 6.2.2 Qiagen (Adnagen) Business Overview
  10. 6.2.3 Qiagen (Adnagen) Circulating Tumor Cells Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Qiagen (Adnagen) Circulating Tumor Cells Product Portfolio
  12. 6.2.5 Qiagen (Adnagen) Recent Developments
  13. 6.3 Advanced Cell Diagnostics
  14. 6.3.1 Advanced Cell Diagnostics Company Information
  15. 6.3.2 Advanced Cell Diagnostics Business Overview
  16. 6.3.3 Advanced Cell Diagnostics Circulating Tumor Cells Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Advanced Cell Diagnostics Circulating Tumor Cells Product Portfolio
  18. 6.3.5 Advanced Cell Diagnostics Recent Developments
  19. 6.4 ApoCell
  20. 6.4.1 ApoCell Company Information
  21. 6.4.2 ApoCell Business Overview
  22. 6.4.3 ApoCell Circulating Tumor Cells Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 ApoCell Circulating Tumor Cells Product Portfolio
  24. 6.4.5 ApoCell Recent Developments
  25. 6.5 Epic Sciences
  26. 6.5.1 Epic Sciences Company Information
  27. 6.5.2 Epic Sciences Business Overview
  28. 6.5.3 Epic Sciences Circulating Tumor Cells Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Epic Sciences Circulating Tumor Cells Product Portfolio
  30. 6.5.5 Epic Sciences Recent Developments
  31. 6.6 Greiner Bio-one GmbH
  32. 6.6.1 Greiner Bio-one GmbH Company Information
  33. 6.6.2 Greiner Bio-one GmbH Business Overview
  34. 6.6.3 Greiner Bio-one GmbH Circulating Tumor Cells Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Greiner Bio-one GmbH Circulating Tumor Cells Product Portfolio
  36. 6.6.5 Greiner Bio-one GmbH Recent Developments
  37. 6.7 Cynvenio
  38. 6.7.1 Cynvenio Company Information
  39. 6.7.2 Cynvenio Business Overview
  40. 6.7.3 Cynvenio Circulating Tumor Cells Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Cynvenio Circulating Tumor Cells Product Portfolio
  42. 6.7.5 Cynvenio Recent Developments
  43. 6.8 SurExamBio-Tech
  44. 6.8.1 SurExamBio-Tech Company Information
  45. 6.8.2 SurExamBio-Tech Business Overview
  46. 6.8.3 SurExamBio-Tech Circulating Tumor Cells Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 SurExamBio-Tech Circulating Tumor Cells Product Portfolio
  48. 6.8.5 SurExamBio-Tech Recent Developments
  49. 6.9 Fluxion Biosciences
  50. 6.9.1 Fluxion Biosciences Company Information
  51. 6.9.2 Fluxion Biosciences Business Overview
  52. 6.9.3 Fluxion Biosciences Circulating Tumor Cells Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Fluxion Biosciences Circulating Tumor Cells Product Portfolio
  54. 6.9.5 Fluxion Biosciences Recent Developments
  55. 6.10 Ikonisys
  56. 6.10.1 Ikonisys Company Information
  57. 6.10.2 Ikonisys Business Overview
  58. 6.10.3 Ikonisys Circulating Tumor Cells Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Ikonisys Circulating Tumor Cells Product Portfolio
  60. 6.10.5 Ikonisys Recent Developments
  61. 6.11 Hangzhou Watson Biotech
  62. 6.11.1 Hangzhou Watson Biotech Company Information
  63. 6.11.2 Hangzhou Watson Biotech Business Overview
  64. 6.11.3 Hangzhou Watson Biotech Circulating Tumor Cells Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Hangzhou Watson Biotech Circulating Tumor Cells Product Portfolio
  66. 6.11.5 Hangzhou Watson Biotech Recent Developments
  67. 6.12 Biocept
  68. 6.12.1 Biocept Company Information
  69. 6.12.2 Biocept Business Overview
  70. 6.12.3 Biocept Circulating Tumor Cells Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Biocept Circulating Tumor Cells Product Portfolio
  72. 6.12.5 Biocept Recent Developments
  73. 6.13 CytoTrack
  74. 6.13.1 CytoTrack Company Information
  75. 6.13.2 CytoTrack Business Overview
  76. 6.13.3 CytoTrack Circulating Tumor Cells Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 CytoTrack Circulating Tumor Cells Product Portfolio
  78. 6.13.5 CytoTrack Recent Developments
  79. 6.14 Guangzhou Wondfo Biotech
  80. 6.14.1 Guangzhou Wondfo Biotech Company Information
  81. 6.14.2 Guangzhou Wondfo Biotech Business Overview
  82. 6.14.3 Guangzhou Wondfo Biotech Circulating Tumor Cells Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Guangzhou Wondfo Biotech Circulating Tumor Cells Product Portfolio
  84. 6.14.5 Guangzhou Wondfo Biotech Recent Developments
  85. 6.15 Celsee
  86. 6.15.1 Celsee Company Information
  87. 6.15.2 Celsee Business Overview
  88. 6.15.3 Celsee Circulating Tumor Cells Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Celsee Circulating Tumor Cells Product Portfolio
  90. 6.15.5 Celsee Recent Developments
  91. 6.16 Clearbridge Biomedics
  92. 6.16.1 Clearbridge Biomedics Company Information
  93. 6.16.2 Clearbridge Biomedics Business Overview
  94. 6.16.3 Clearbridge Biomedics Circulating Tumor Cells Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Clearbridge Biomedics Circulating Tumor Cells Product Portfolio
  96. 6.16.5 Clearbridge Biomedics Recent Developments
  97. 6.17 ANGLE plc
  98. 6.17.1 ANGLE plc Company Information
  99. 6.17.2 ANGLE plc Business Overview
  100. 6.17.3 ANGLE plc Circulating Tumor Cells Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 ANGLE plc Circulating Tumor Cells Product Portfolio
  102. 6.17.5 ANGLE plc Recent Developments
7 North America
  1. 7.1 North America Circulating Tumor Cells Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Circulating Tumor Cells Market Size by Country (2021-2026)
  3. 7.3 North America Circulating Tumor Cells Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Circulating Tumor Cells Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Circulating Tumor Cells Market Size by Country (2021-2026)
  3. 8.3 Europe Circulating Tumor Cells Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Circulating Tumor Cells Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Circulating Tumor Cells Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Circulating Tumor Cells Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Circulating Tumor Cells Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Circulating Tumor Cells Market Size by Country (2021-2026)
  3. 10.3 South America Circulating Tumor Cells Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Circulating Tumor Cells Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Circulating Tumor Cells Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Circulating Tumor Cells Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst